Haemaccel (a registered trademark) is a type of intravenous colloid used in the prevention or treatment of shock associated with reduction in effective circulating blood volume due to hemorrhage, loss of plasma (burns, peritonitis, pancreatitis, crush injuries), or loss of water and electrolytes from persistent vomiting and diarrhea. Haemaccel contains degraded gelatin.
Cite error: Invalid
parameter "group" is allowed only.
<references />, or
<references group="..." />
|40px||This medical treatment-related article is a stub. You can help ssf by expanding it.|
|This pharmacology-related article is a stub. You can help ssf by expanding it.|